Keith Gollust Net Worth

Keith Gollust biography

Keith R. Gollust serves as Independent Director of the Company. Mr. Gollust served on our Board since July of 2016, on the board of directors of Synta from July 2002 through the Merger in July 2016 and as Chairman of the Synta board of directors from September 2002 through the Merger in July 2016. Mr. Gollust is a private investor and President of Gollust Management, Inc., the general partner of Wyandanch Partners, an investment partnership. In the past, Mr. Gollust has is served as a director of numerous public and private companies, and he currently serves on the board of VINDEX, LLC, a private company. Mr. Gollust received a B.A. from Princeton University and an M.S.I.A. from Carnegie Mellon University.

What is the salary of Keith Gollust?

As the Independent Director of Madrigal Pharmaceuticals Inc, the total compensation of Keith Gollust at Madrigal Pharmaceuticals Inc is $662,500. There are 11 executives at Madrigal Pharmaceuticals Inc getting paid more, with Paul Friedman having the highest compensation of $6,093,190.

How old is Keith Gollust?

Keith Gollust is 74, he's been the Independent Director of Madrigal Pharmaceuticals Inc since 2016. There are 2 older and 14 younger executives at Madrigal Pharmaceuticals Inc. The oldest executive at Madrigal Pharmaceuticals Inc is David Milligan, 79, who is the Independent Director.

What's Keith Gollust's mailing address?

Keith's mailing address filed with the SEC is C/O MADRIGAL PHARMACEUTICALS, INC., 200 BARR HARBOR DRIVE, SUITE 400, WEST CONSHOHOCKEN, PA, 19428.

Insiders trading at Madrigal Pharmaceuticals Inc

Over the last 8 years, insiders at Madrigal Pharmaceuticals Inc have traded over $471,222,585 worth of Madrigal Pharmaceuticals Inc stock and bought 443,785 units worth $79,114,183 . The most active insiders traders include Bros. Advisors Lp667, L.P.B..., Paul A Friedman a Bros. Advisors Lp667, L.P.B.... On average, Madrigal Pharmaceuticals Inc executives and independent directors trade stock every 56 days with the average trade being worth of $20,602,093. The most recent stock trade was executed by William John Sibold on 9 September 2024, trading 6,363 units of MDGL stock currently worth $1,551,490.

What does Madrigal Pharmaceuticals Inc do?

madrigal pharmaceuticals inc. is a biotechnology company based out of calle laguna del marquesado nª 19, nave 16 edificio adriana 1ª planta, polígono industrial la resina (villaverde), madrid, community of madrid, spain.

Madrigal Pharmaceuticals Inc executives and stock owners

Madrigal Pharmaceuticals Inc executives and other stock owners filed with the SEC include:

• Paul Friedman,
  Chairman of the Board, Chief Executive Officer
• Rebecca Taub,
  President of Research and Development, Chief Medical Officer, Director
• Brian Lynch,
  Senior Vice President, General Counsel
• Marc Schneebaum,
  Chief Financial Officer, Senior Vice President
• James Daly,
  Independent Director
• Dr. Paul A. Friedman M.D.,
  Chairman & CEO
• Dr. Rebecca A. Taub M.D.,
  Founder, Chief Medical Officer, Pres of R&D and Director
• Remy Sukhija,
  Sr. VP & Chief Commercial Officer
• Brian J. Lynch J.D.,
  Sr. VP & Gen. Counsel
• Brian J. Lynch,
  Sr. VP & Gen. Counsel
• Kenneth Bate,
  Independent Director
• Richard Levy,
  Independent Director
• Keith Gollust,
  Independent Director
• David Milligan,
  Independent Director
• Frederick Craves,
  Lead Independent Director
• Remy Sukhija,
  Senior Vice President, Chief Commercial Officer
• Edward Chiang,
  Sr. VP of Clinical & Technical Operations
• Dr. Stephen Dodge M.B.A., Pharm.D.,
  Sr. VP & Global Head of Medical Affairs
• Dr. Robert E. Waltermire Ph.D.,
  Chief Pharmaceutical Devel. Officer
• Thomas W. Hare,
  Sr. VP of Clinical Management
• Dr. Kianoush Motesharei Ph.d.,
  Sr. VP of Bus. & Corp. Devel.
• Alex G. Howarth,
  Chief Financial Officer
• Bros. Advisors Lp667, L.P.B...,
  
• Bros. Advisors Lp667, L.P.B...,
  
• Chen Schor,
  Former President and CEO
• Wendy E Rieder,
  Former SVP, Gen. Counsel
• City Capital Llc Bay,
  Director
• City Capital Llc Bay City C...,
  
• Alex G. Howarth,
  Chief Financial Officer
• Robert E. Waltermire,
  Senior VP, Chief Pharma Dev.
• Bros. Advisors Lp Baker,
  
• Shannon T Kelley,
  General Counsel
• William John Sibold,
  President and CEO
• Carole Huntsman,
  Chief Commercial Officer
• Fred B Craves,